Chelsea Therapeutics International Given New $7.00 Price Target at Ladenburg Thalmann (CHTP)
Stock analysts at Ladenburg Thalmann upped their price objective on shares of Chelsea Therapeutics International (NASDAQ:CHTP) to $7.00 in a report issued on Wednesday, Stock Ratings Network.com reports. Ladenburg Thalmann’s price objective suggests a potential upside of 204.35% from the stock’s previous close.
Chelsea Therapeutics International (NASDAQ:CHTP) traded up 114.74% on Wednesday, hitting $4.939. 27,920,174 shares of the company’s stock traded hands. Chelsea Therapeutics International has a 1-year low of $0.76 and a 1-year high of $4.53. The stock’s 50-day moving average is $3.73 and its 200-day moving average is $3.12. The company’s market cap is $349.5 million.
A number of other firms have also recently commented on CHTP. Analysts at Needham & Company raised their price target on shares of Chelsea Therapeutics International from $4.00 to $8.00 in a research note to investors on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at Wedbush reiterated an “outperform” rating on shares of Chelsea Therapeutics International in a research note to investors on Friday, January 10th. Finally, analysts at JMP Securities initiated coverage on shares of Chelsea Therapeutics International in a research note to investors on Thursday, December 19th. They set an “outperform” rating and a $8.00 price target on the stock. Five research analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and an average price target of $7.00.
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.